Testing effectiveness (Phase 2)UnknownNCT03902197What this trial is testingCD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL PatientsWho this might be right forAcute Lymphoblastic Leukemia Xuanwu Hospital, Beijing 50
Testing effectiveness (Phase 2)Study completedNCT00802113What this trial is testingAutologous and Allogeneic Transplant for Relapsed LymphomaWho this might be right forNon-Hodgkin's LymphomaHodgkins Disease Columbia University 30
Testing effectiveness (Phase 2)Ended earlyNCT05272813What this trial is testingInvestigate the Efficacy and Safety of MS-553 in CLL/SLLWho this might be right forLymphocytic LeukemiaSmall Lymphocytic Lymphoma Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. 13
Large-scale testing (Phase 3)Study completedNCT01197560What this trial is testingStudy of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma Celgene 111
Early research (Phase 1)Looking for participantsNCT05963217What this trial is testingStudy of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLWho this might be right forRelapsed or Refractory CD19+ B-cell LymphomaRelapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma University Health Network, Toronto 19
Not applicableLooking for participantsNCT06678282What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ LeukemiaWho this might be right forB-NHLB-ALL Shenzhen Genocury Biotech Co., Ltd. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724782What this trial is testingMulti-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCLWho this might be right forPTCL-NOS Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Ended earlyNCT03547115What this trial is testingVoruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AMLWho this might be right forFollicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more MEI Pharma, Inc. 84
Testing effectiveness (Phase 2)UnknownNCT02134262What this trial is testingGene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesWho this might be right forRelapsed or Refractory B-Cell Non-Hodgkin Lymphoma Jichi Medical University 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06757387What this trial is testingChidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell LymphomaWho this might be right forPeripheral T-cell Lymphoma Peking University Cancer Hospital & Institute 45
Testing effectiveness (Phase 2)Study completedNCT03770416What this trial is testingNivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System LymphomaWho this might be right forCentral Nervous System B-Cell Non-Hodgkin LymphomaRecurrent Central Nervous System LymphomaRefractory Central Nervous System Lymphoma M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00831597What this trial is testingBendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Pharmatech 61
Testing effectiveness (Phase 2)Looking for participantsNCT07502768What this trial is testingTislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell LymphomaWho this might be right forExtranodal NK/T-cell LymphomaNK/T-cell LymphomaRelapsed or Refractory NK/T-Cell Lymphoma Rong Tao 107
Early research (Phase 1)Study completedNCT00741403What this trial is testingA Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced MalignanciesWho this might be right forAdvanced CancerMetastatic CancerLymphoma+2 more Cornerstone Pharmaceuticals 39
Early research (Phase 1)Looking for participantsNCT06792734What this trial is testingPhase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell LymphomasWho this might be right forLymphoma, B-Cell Bantam Pharmaceuticals 24
Very early researchUnknownNCT06277011What this trial is testingSafety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical ResearchWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma Anhui Provincial Hospital 18
Early research (Phase 1)Active Not RecruitingNCT02159495What this trial is testingGenetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell NeoplasmWho this might be right forAdult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more City of Hope Medical Center 31
Large-scale testing (Phase 3)Looking for participantsNCT07409428What this trial is testingA Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCLWho this might be right forRelapsed/Refractory Diffuse Large B-Cell Lymphoma Hutchmed 240
Testing effectiveness (Phase 2)Ended earlyNCT00479167What this trial is testingA Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's LymphomaWho this might be right forFollicular Lymphoma Rush University Medical Center 1
Testing effectiveness (Phase 2)UnknownNCT05875428What this trial is testingMitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-Cell Lymphoma CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 104